Lynozyfic Patient Assistance Program

(linvoseltamab-gcpt)

Key Takeaways

  1. Lynozyfic® (linvoseltamab-gcpt) is an intravenous (IV) biologic immunotherapy approved for adults with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy.
  2. Lynozyfic is a BCMA×CD3 T-cell-engaging bispecific monoclonal antibody that helps the immune system recognize and destroy multiple myeloma cells.
  3. Lynozyfic carries an FDA Boxed Warning for cytokine release syndrome (CRS) and neurologic toxicity, including immune effector cell-associated neurotoxicity syndrome (ICANS), and is available only through the LYNOZYFIC REMS Program.
  4. Prescription Hope may help eligible individuals access manufacturer-sponsored patient assistance programs that can make Lynozyfic more affordable.

 

Introduction

Multiple myeloma is a cancer of plasma cells that often becomes more difficult to treat after several lines of therapy. Patients whose disease returns or no longer responds to standard treatments may require newer immunotherapies designed to help the body’s immune system target cancer cells more effectively.

Lynozyfic is an intravenous biologic immunotherapy approved for adults with relapsed or refractory multiple myeloma who have received multiple prior therapies. By bringing T cells into direct contact with myeloma cells, Lynozyfic helps the immune system recognize and destroy cancer cells.

Because Lynozyfic is a specialty biologic medication administered through IV infusion, treatment costs can be high. Many people searching for a Lynozyfic patient assistance program are looking for ways to reduce their prescription expenses.

Prescription Hope offers qualified patients needing access to Lynozyfic an affordable solution by providing application and management services for those looking to enroll in the Lynozyfic Patient Assistance Program.

 

What Is the Lynozyfic Patient Assistance Program?

Understanding Lynozyfic Prescription Assistance

If you are looking for help paying for Lynozyfic, consider the Lynozyfic patient assistance program.

A patient assistance program is offered by some pharmaceutical manufacturers to help with the cost of name-brand medication for qualified patients. The patient assistance programs allow those qualified patients to receive access to the name-brand medications they need at a low cost.

However, some patients become discouraged from utilizing the services of a patient assistance program because they are known to require extensive documentation, research, and communication with healthcare providers and the manufacturer. This may result in frustration and exasperation for the patient as they try to navigate the system.

Prescription Hope can help.

 

How Expert Advocates Help Make Lynozyfic More Affordable

Personalized Medication Assistance

Lynozyfic enrollment assistance through Prescription Hope helps qualified patients get access to the name-brand medication they need at a fraction of the retail cost.

Our patient support services help qualified patients navigate the application process for a patient assistance program, and help qualified patients retain access long-term. Our team of prescription assistance specialists is available to take care of any administrative needs through the process, such as taking care of forms, documents, and signatures, communication with healthcare providers, coordinating with manufacturers, and more.

Ongoing Patient Support

Prescription Hope is here to help you with your prescription access and the application process, but we also understand the need for long-term medication assistance. Some of the ways we support you through specialty medication assistance are as follows: prescription refill support, document updates, yearly renewals, program monitoring, and more.

Navigating Multiple Myeloma Treatment Costs

While multiple myeloma is a difficult diagnosis to navigate, your ability to get Lynozyfic cost assistance doesn’t have to be. Multiple myeloma medication assistance is just one of the many ways Prescription Hope offers prescription cost help to our qualified patients.

Whatever the brand-name medication you are looking for to help you in this difficult time of treatment, Prescription Hope can be by your side at a simple cost of $70.00 per month, per medication. There are no hassles, hidden fees, or add-ons associated with this fee.

If you don’t qualify for our services, our team will still help you find other ways to save money on your needed brand-name medication, such as substitute medications, discount cards, and coupons. If we cannot help you save, you pay us nothing!

 

Lynozyfic Patient Assistance Eligibility

General Eligibility Requirements

Patients looking to know who qualifies for Lynozyfic assistance should first clarify the medication assistance requirements. To properly determine what criteria you need to meet, apply to Prescription Hope.

Patient assistance programs will normally set requirements in these categories:

Income: Every program has a different requirement for a patient’s income status to qualify.

Insurance: Every program also has a different requirement for a patient’s insurance coverage.

Prescription: Patients must hold a prescription for their needed brand-name medication from their healthcare provider in order to qualify.

U.S. Residency: Only U.S. citizens can qualify for a prescription assistance program.

Simple Enrollment With Expert Support

Getting Started With Enrollment

Are you looking for patient assistance registration? Do you feel overwhelmed by the Lynozyfic application process? Enrollment with Prescription Hope only takes 6 easy steps:

  1. Submit Information: Registration can be done online in just a few minutes.
  2. Advocate Contact: You will be contacted by a patient advocate within 1-2 business days of receiving your application.
  3. Document Collection: Our team will collect any documents following your prequalification.
  4. Provider Coordination: We will also connect with your healthcare provider to obtain any needed signatures.
  5. Program Submission: Once everything is in order, we will submit your application in your stead and continue to communicate with the pharmaceutical manufacturer.
  6. Medication Delivery: After your application is approved, your medication will be shipped directly to your door or doctor’s office, typically within 2 weeks.

Understanding Lynozyfic

How Lynozyfic Works

Lynozyfic is a bispecific monoclonal antibody that binds to:

  • B-cell maturation antigen (BCMA) on multiple myeloma cells
  • CD3 receptors on T cells

By simultaneously binding BCMA on myeloma cells and CD3 on T cells, Lynozyfic redirects T cells to recognize and destroy BCMA-expressing cancer cells.

This targeted immune activation enables the body’s own immune system to attack multiple myeloma cells while sparing most healthy tissues.

What Conditions Does Lynozyfic Treat?

Lynozyfic is FDA-approved for the treatment of adults with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy, including:

  • A proteasome inhibitor (PI)
  • An immunomodulatory agent (IMiD)
  • An anti-CD38 monoclonal antibody

This indication was granted under the FDA’s Accelerated Approval pathway based on overall response rate and duration of response. Continued approval may depend on verification and description of clinical benefit in confirmatory clinical trials.

Benefits of Treatment

For appropriate patients with relapsed or refractory multiple myeloma, Lynozyfic may:

  • Produce clinically meaningful responses in many heavily pretreated patients
  • Activate the immune system to target BCMA-expressing myeloma cells
  • Offer a treatment option after multiple prior therapies have failed
  • Provide durable responses in some patients
  • Offer a fixed dosing schedule after completion of the initial step-up dosing regimen

Because approval was granted under Accelerated Approval, additional studies are ongoing to confirm long-term clinical benefit.

 

Important Safety Information and Side Effects

Lynozyfic carries an FDA Boxed Warning.

The boxed warning highlights the risk of:

  • Cytokine Release Syndrome (CRS), including serious or life-threatening reactions
  • Neurologic toxicity, including Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS)

Because of these risks:

  • Treatment begins with a required step-up dosing schedule.
  • Patients receive premedications before early doses.
  • Close monitoring is required during and after treatment.
  • Lynozyfic is available only through the LYNOZYFIC REMS Program.

There are no contraindications listed in the FDA Prescribing Information.

The most commonly reported adverse reactions include:

  • Musculoskeletal pain
  • Cytokine release syndrome (CRS)
  • Cough
  • Upper respiratory tract infection
  • Diarrhea
  • Fatigue
  • Pneumonia
  • Nausea
  • Headache
  • Shortness of breath (dyspnea)
  • Fever (pyrexia)

Common laboratory abnormalities include:

  • Decreased lymphocyte count
  • Decreased neutrophil count
  • Decreased hemoglobin
  • Decreased white blood cell count

Patients should promptly report persistent or worsening side effects to their healthcare provider.

Patients should discuss the following risks with their healthcare provider:

  • Cytokine Release Syndrome (CRS)
  • Neurologic toxicity, including ICANS
  • Serious or fatal infections
  • Opportunistic infections
  • Neutropenia and other cytopenias requiring regular monitoring
  • Hypogammaglobulinemia
  • Hepatotoxicity
  • Infusion-related reactions
  • Need for regular blood count and liver function monitoring

Patients should promptly report symptoms such as fever, chills, persistent cough, confusion, severe fatigue, or new neurologic symptoms.

Lynozyfic may cause fetal harm when administered during pregnancy. Females of reproductive potential should use effective contraception during treatment and for 4 months after the last dose. Patients should notify their healthcare provider immediately if pregnancy occurs during treatment.

Do not breastfeed during treatment and for 4 months after the final dose because of the potential for serious adverse reactions in a breastfed child.

No formal clinical drug-drug interaction studies have been conducted with Lynozyfic. Patients should inform their healthcare provider about all prescription medications, over-the-counter medicines, vitamins, and herbal supplements before beginning therapy.

Lynozyfic is administered by intravenous (IV) infusion by healthcare professionals experienced in treating hematologic malignancies and immunotherapy-related toxicities. Treatment begins with a required step-up dosing schedule, and patients receive premedications to reduce the risk of cytokine release syndrome and infusion-related reactions. Patients should be hospitalized for at least 24 hours after each of the first two step-up doses and remain near an appropriate healthcare facility during the early treatment period because of the risk of CRS and neurologic toxicity. Ongoing monitoring includes complete blood counts, liver function tests, and evaluation for CRS, neurologic toxicity, and infections.

Access to Multiple Medications

Support Beyond Lynozyfic

Some patients may be searching for multiple medication assistance programs while undergoing specialty biologic support, due to their condition. Prescription Hope offers prescription medication access services for hundreds of brand-name medications to qualified patients, helping them to maintain the important things in life while undergoing treatment. No matter how many medications you need, Prescription Hope offers the same great service at the same great price point of $70.00 per month, per medication.

Why Choose Prescription Hope

Patient-Focused Medication Support

For 20 years, Prescription Hope has offered prescription affordability support and patient-centered prescription help to qualified patients across the nation. We are proud to offer Lynozyfic assistance through Prescription Hope.

Simplified Access to Prescription Medications

All of Prescription Hope’s medication access support is available for just $70.00 per month, per medication. There are no hidden fees, no add-ons, and no long contracts.

Ongoing Prescription Assistance

Not only do we offer specialty prescription assistance to qualified patients, but we also offer long-term medication support. Our team will take care of refill scheduling, document updates, yearly renewals, and more.

Network Access

Our network spans across hundreds of name-brand medications and the prescription assistance programs associated with them.

If you need Lynozyfic and you need assistance in finding savings options, enroll with Prescription Hope to see how we can help you afford it today!

Frequently Asked Questions

It's Easy!

Submit Enrollment Form

Getting started is free and easy! Simply complete the online enrollment form. 

Receive Welcome Call

An Enrollment Specialist will reach out to you for a personalized welcome call.

We Manage The Process

Your dedicated team manages your account month after month, allowing you to focus on what matters most—your health.

Helpful Articles

Latest News & Stories

Save Money On Your Prescriptions Today!